Malaria is a preventable and treatable condition and remains the most important parasitic disease globally [6]. In 2017, it was still endemic in 80 countries, placing 3.7 billion people at risk. Considerable progress has been made due to aggressive malaria control and elimination efforts since 2000, resulting in a global reduction of 40% in morbidity and 60% in mortality [2]. Many efforts have been made to minimize malaria transmission worldwide; however, this infection remains high among humans [42]. All species of Plasmodium have been documented in Indonesia. Plasmodium vivax is the predominant species except in Papua where P. falciparum slightly predominates [5, 43, 44].
Plasmodium falciparum is the most prevalent malaria parasite in the WHO African region, accounting for 99.7% of estimated malaria cases in 2017, as well as in the WHO regions of South-East Asia Region (62.8%), the Eastern Mediterranean (69%) and the Western Pacific (71.9%). Plasmodium vivax is the predominant parasite in the WHO region of the Americas (74.1%) [2]. Plasmodium vivax contributed 4% of the total global cases in 2015, but outside Africa the proportion was 41% among all malaria infections. Its high burden of disease is maintained in part due to dormant liver stage parasite forms known as hypnozoites which can induce clinical relapse episodes [45].
In the present study, there were more male patients infected with malaria than female patients, which is similar to the results of a study in South Sorong [46]. One hundred two subjects (56%) were infected with P. falciparum. This study also shows that the most common type of Plasmodium infection in Sorong, West Papua, is P. falciparum. This is similar with other provinces in Indonesia and in Manokwari, West Papua, P. falciparum is the predominant malaria species [44, 47].
About 42.3% of malaria cases in our study was among children < 5 year old. According to WHO data in 2017, they are the most vulnerable group affected by malaria. They accounted for 61% (266,000) of all malaria deaths worldwide [2].
Cytopenia is a disorder in which the production of one or more blood cell types ceases or is greatly reduced. The types of cytopenia are anaemia, which is a reduction in red blood cells (RBCs); leukopenia, which is a reduction in WBCs; neutropenia (neutrophils make up over half of all WBCs), which is a deficiency in neutrophils; and thrombocytopenia, which is deficiency in platelets. Bicytopenia is defined as a condition in which two out of three cell lines (RBCs, WBCs, and platelets) are reduced. The simultaneous reduction in all three formed cell lines is termed pancytopenia [48]. These kinds of cytopenias are not uncommon in malaria; bone marrow diagnosis of adults with bicytopenia and pancytopenia has shown that 3% of bicytopenia and 6% of pancytopenia were caused by malaria [49, 50].
Anaemia is also a common manifestation, particularly in infants with P. vivax and in children with P. knowlesi infection [51-53]. Anaemia is one of the most common complications in malaria infection, especially in younger children and pregnant women in high transmission areas [54, 55].
The pathogenesis of anaemia during malaria infection is not clearly understood. However, it is estimated that the main targets of parasites are RBCs, which results in damage to RBCs, acceleration of parasite growth and nonparasitic removal [56], bone marrow dysfunction [57], and the level of parasitaemia [58]. Anaemia in malaria, however, is associated with a combination of haemolysis of parasitized RBCs, accelerated removal of both parasitized and unparasitized RBCs, depressed and ineffective erythropoiesis due to tumor necrosis factor alpha, anaemia of chronic disease, and splenic phagocytosis or pooling [59-61].
This study showed that haematological abnormalities in children with malaria infection are common. Some subjects (50%) had a Hb level between 5.1 and 10 gr/dL. The prevalence of anaemia in This study was 77.4%; 14.8% of subjects had mild anaemia, 35.7% had moderate anaemia, and 26.9% had severe anaemia. The rate of anaemia in children < 5 years old was higher than that in children 5-10 years old and > 10 years old, with a mean Hb of 8.71 gr/dL. Data from household surveys conducted in 25 high-burden African countries between 2015 and 2019 show that, among children < 5 years who tested positive for malaria, the prevalence of moderate to severe anaemia was between 9% - 76.3% [62]. A laboratory trial study of 30 patients in Iran observed significantly lower values of Hb/dL, haematocrit (Ht)%, mean corpuscular volume (MCV)/ fl and mean corpuscular haemoglobin (MCH)/ μl, WBC/ μl, and platelet/ μl among malaria-infected children compared to healthy children [13, 15, 63, 64]. Our findings were consistent with these previous reports.
There are various hypotheses about thrombocytopenia that occurs in malaria infections. Thrombocytopenia seems to occur through peripheral damage [65], excessive removal of platelets by spleen pooling [66, 67] and platelet consumption by the process of disseminated intravascular coagulopathy (DIC) [68]. Sufficient or increased numbers of megakaryocytes in the bone marrow affect the decrease in thrombopoiesis, which is a possible cause of thrombocytopenia in malaria [66]. The destruction of circulating platelets mediated by immunity has been postulated as the cause of thrombocytopenia seen in malaria infections. Platelets have also been shown to mediate clumping of erythrocytes infected with P. falciparum [69]. This can cause apparent thrombocytopenia. Patients infected with malaria experience increased levels of specific immunoglobulin G (IgG) in the blood that binds to malaria antigens bound to platelets, which may lead to acceleration of platelet destruction [23]. Previous studies revealed that platelet aggregation, which is the clumping of platelets, was incorrectly calculated as a single platelet by the analyzer, causing pseudothrombocytopenia [13]. In addition, during malaria infection, endothelial activation is activated and can contribute to the loss of endothelium barrier function and organ dysfunction. This process can use released platelets and proteins as important regulators of endothelial permeability, resulting in thrombocytopenia [70]. However, thrombocytopenia in malaria infection has also been associated with sequestration and pooling of platelets in the spleen, immune-mediated destruction of circulating platelets, and platelets mediating the clumping of P. falciparum-infected erythrocytes, leading to pseudothrombocytopenia [13, 63, 69].
Thrombocytopenia was seen in 97 children (53.3%) and was highly significant in the age group > 10 years, with a median 105 x 103/µL in this study.
It is found mostly in P. falciparum infection, as many as 65 (35.7%). Thrombocytopenia was observed in malaria-infected children in this study, which is consistent with earlier reports [13, 63]. There were both qualitative and quantitative changes in platelet abnormalities in malaria. Platelet counts were significantly reduced in children infected with malaria. A study conducted in Thailand-Myanmar border showed that thrombocytopenia occured. This observation may imply that thrombocytopenia can be a marker of Plasmodium infection [13, 71-73].
In the present study overall, when compared between malaria species in uncomplicated cases, Hb and platelet value in the P. falciparum infection was lower than P. vivax infection as well as the platelet value (Table 7) with p value 0.001. These figures were in good agreement with studies done by Latif et al. showing P. falciparum-associated anaemia and thrombocytopenia compared to P. vivax infection, (8.1 ± 2.2 g/dL vs 11 ± 3.2 g/dL and 60.338 ± 50.6 x 103/µL vs 77.907 ± 78.4 x 103/µL, respectively) [21]. A study by Hyder et al. also found the same thing with the following results 10.1921 ± .33157 g/dL vs 11.3306 ± .29730 g/dL and 88.0239 ± 1.17476/µL x 103/µL vs 98.1763 ± .99502 x 103/µL [30].
On the contrary, studies, such as Goyal et al. [74], Nadwani et al. [75], Sajjanar et al. [76], George and Alexander [77], Rodriguez-Monrale et al. [78] have shown P. vivax-associated anaemia and thrombocytopenia. Ullah et al. showed something different where P. falciparum-associated anaemia (9.9 ± 4.48 g/dL vs 10.7 ± 2.36 g/dL) and P. vivax-associated thrombocytopenia (135.8 ± 89.4 x 103/µL vs 222 ± 118.7 x 103/µL) [29].
In the recent years, there have been reported many severe vivax malaria cases [75, 76, 79]. The current dogma has been that P. falciparum can be severe and life-threatening, whereas P. vivax tends to be mild [80]. However, there is currently growing evidence that P. vivax can cause significant morbidity and even mortality in endemic areas [81]. Malaria severity is a function of parasite virulence, degree of parasitaemia, sequestration and host immune competence which in turn depends on factors, namely. age, regional transmission intensity, nutritional status and genetic susceptibility [82-86]. Another hypothesis of Price et al. that an increase in the P. vivax parasite resistant to chloroquine in recent years is one of the main triggers of the new severe vivax malaria [82]. All these variables make the risk and spectrum of malaria complications different around the world [83-85].
Price et al. found that P. vivax infection associated with severe and fatal malaria particularly in young children in Timika, Papua [82]. Otherwise, severe malaria was found more in falciparum malaria cases (7.1%) than in vivax malaria (4.9%) and mixed malaria (1.1%). This study still has shortcomings where there are no data on the number of parasites and chloroquine resistance.
This study has shown, however, that there was no significant difference in total white blood cell count in malaria-infected children. Leukopenia was seen in only 17% of children. A study by Maina et al. also showed that there was no significant difference in the total white blood cell count in malaria-infected children compared to control subjects [13]. The difference in values can be related to environmental factors, socioeconomic status, or malaria immunity, among other factors [14, 56, 86]. Different views have been expressed on the total WBCs in subjects infected with malaria because leukopenia has been reported by several authors [14, 63, 73], and leukocytosis has also been documented by other authors [13, 15, 65].
Leukocyte value in P. falciparum (5.55 x 103/µL) was lower than in P. vivax infection (7.2 x 103/µL). Similar outcome was also reported in a study conducted by Latif et al. showing leukocyte in P. falciparum (8,906 ± 1.06 x 103/µL) compared to P. vivax infection (11,868 ± 2.34 x 103/µL) was lower [21]. This was in contrast to the findings reported by Ullah et al., which showed that leukocyte in P. vivax (8.7 ± 4.5 × 103/µL) was lower than in P. falciparum infection (10.4 ± 11.4 × 103/µL) [29].
This study showed lymphocytopenia in 97 children (53.3%). The study has further revealed that there were no statistically significant differences in granulocyte and lymphocyte counts between malaria-infected and noninfected children, and these findings are in agreement with many earlier reports [13-15, 56, 72, 86-88] but disagree with the findings of George and Ewelike-Ezeani [63]. In some cases of acute malaria, however, lymphocytopenia has been reported, but this has been associated with redistribution of lymphocytes with sequestration in the spleen [89, 90].
Generally, clinical symptoms are not significantly associated with a malaria diagnosis, and only one variable shows a significant relationship, pale, with a p value of 0.001. The first symptoms of malaria are nonspecific and characterized by headache, fatigue, abdominal discomfort, and muscle and joint aches, followed by fever, chills, perspiration, anorexia, vomiting and worsening malaise. These features often lead to overdiagnosis of malaria in developing countries, where diagnosis is frequently based only on clinical judgment with limited resources for parasitological testing [91].
Conversely, in children, these manifestations of uncomplicated malaria can be misinterpreted and attributed to other prevalent infections, such as pneumonia, gastroenteritis, and sepsis [92]. In high transmission areas, high and repeated exposure to parasites has an impact on the acquisition of immunity, resulting in a high proportion of asymptomatic infections, particularly in older children and adults [93].
There are several limitations in this study. First, this was a retrospective study. Some data of the haematological and microscopic results retrieved from medical records were not provided. Second, there was no control group in this study, therefore association between haematological markers in malaria and non-malaria infected groups could not be stated.